These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 8325337)

  • 1. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells.
    Moll H; Fuchs H; Blank C; Röllinghoff M
    Eur J Immunol; 1993 Jul; 23(7):1595-601. PubMed ID: 8325337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
    Moll H; Flohé S; Röllinghoff M
    Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
    Ritter U; Meissner A; Scheidig C; Körner H
    Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine epidermal Langerhans cells are potent stimulators of an antigen-specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis.
    Will A; Blank C; Röllinghoff M; Moll H
    Eur J Immunol; 1992 Jun; 22(6):1341-7. PubMed ID: 1601029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal Langerhans cells are critical for immunoregulation of cutaneous leishmaniasis.
    Moll H
    Immunol Today; 1993 Aug; 14(8):383-7. PubMed ID: 8397776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-bearing dendritic cells in the draining lymph nodes of contact sensitized mice: cluster formation with lymphocytes.
    Cumberbatch M; Illingworth I; Kimber I
    Immunology; 1991 Sep; 74(1):139-45. PubMed ID: 1937567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of chemokines and accessory cells in the immunoregulation of cutaneous leishmaniasis.
    Moll H
    Behring Inst Mitt; 1997 Mar; (99):73-8. PubMed ID: 9303204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD; Locksley RM; Tubbs C; Raff HV
    J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major.
    Doherty TM; Coffman RL
    J Immunol; 1993 Jun; 150(12):5476-83. PubMed ID: 8515072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration.
    Cumberbatch M; Kimber I
    Immunology; 1992 Feb; 75(2):257-63. PubMed ID: 1551688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA; Ogunremi O; Menon JN
    Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
    Titus RG; Lima GC; Engers HD; Louis JA
    J Immunol; 1984 Sep; 133(3):1594-600. PubMed ID: 6205088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.
    Bertholet S; Debrabant A; Afrin F; Caler E; Mendez S; Tabbara KS; Belkaid Y; Sacks DL
    Infect Immun; 2005 Oct; 73(10):6620-8. PubMed ID: 16177338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
    Moll H; Scollay R
    Eur J Immunol; 1989 Feb; 19(2):307-14. PubMed ID: 2467816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice.
    Milon G; Titus RG; Cerottini JC; Marchal G; Louis JA
    J Immunol; 1986 Feb; 136(4):1467-71. PubMed ID: 2418115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC class II expression by Langerhans' cells and lymph node dendritic cells: possible evidence for maturation of Langerhans' cells following contact sensitization.
    Cumberbatch M; Gould SJ; Peters SW; Kimber I
    Immunology; 1991 Nov; 74(3):414-9. PubMed ID: 1769690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
    Solbach W; Forberg K; Kammerer E; Bogdan C; Röllinghoff M
    J Immunol; 1986 Jul; 137(2):702-7. PubMed ID: 3487578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.
    Scott P
    J Immunol; 1991 Nov; 147(9):3149-55. PubMed ID: 1833466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.